Joanna Watt - Publications

Pharmacology University of Oxford, Oxford, United Kingdom 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Su X, Dohle W, Mills SJ, Watt JM, Rossi AM, Taylor CW, Potter BVL. Inositol Adenophostin: Convergent Synthesis of a Potent Agonist of d--Inositol 1,4,5-Trisphosphate Receptors. Acs Omega. 5: 28793-28811. PMID 33195933 DOI: 10.1021/acsomega.0c04145  0.44
2020 Baszczyňski O, Watt JM, Rozewitz MD, Fliegert R, Guse AH, Potter BVL. Synthesis of phosphonoacetate analogues of the second messenger adenosine 5'-diphosphate ribose (ADPR). Rsc Advances. 10: 1776-1785. PMID 31934327 DOI: 10.1039/C9Ra09284F  0.44
2019 Baszczyňski O, Watt JM, Rozewitz MD, Guse AH, Fliegert R, Potter BVL. Synthesis of Terminal Ribose Analogues of Adenosine 5'-Diphosphate Ribose as Probes for the Transient Receptor Potential Cation Channel TRPM2. The Journal of Organic Chemistry. 84: 6143-6157. PMID 30978018 DOI: 10.1021/Acs.Joc.9B00338  0.44
2019 Kühn FJP, Watt JM, Potter BVL, Lückhoff A. Different substrate specificities of the two ADPR binding sites in TRPM2 channels of Nematostella vectensis and the role of IDPR. Scientific Reports. 9: 4985. PMID 30899048 DOI: 10.1038/S41598-019-41531-4  0.44
2018 Zhang B, Watt JM, Cordiglieri C, Dammermann W, Mahon MF, Flügel A, Guse AH, Potter BVL. Small Molecule Antagonists of NAADP-Induced Ca Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease. Scientific Reports. 8: 16775. PMID 30425261 DOI: 10.1038/S41598-018-34917-3  0.44
2018 Watt JM, Thomas MP, Potter BVL. Synthetic cADPR analogues may form only one of two possible conformational diastereoisomers. Scientific Reports. 8: 15268. PMID 30323284 DOI: 10.1038/S41598-018-33484-X  0.44
2017 Watt JM, Graeff R, Thomas MP, Potter BVL. Second messenger analogues highlight unexpected substrate sensitivity of CD38: total synthesis of the hybrid "L-cyclic inosine 5'-diphosphate ribose". Scientific Reports. 7: 16100. PMID 29170518 DOI: 10.1038/S41598-017-16388-0  0.44
2017 Kyratsous NI, Bauer IJ, Zhang G, Pesic M, Bartholomäus I, Mues M, Fang P, Wörner M, Everts S, Ellwart JW, Watt JM, Potter BVL, Hohlfeld R, Wekerle H, Kawakami N. Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy. Proceedings of the National Academy of Sciences of the United States of America. PMID 28716943 DOI: 10.1073/Pnas.1701806114  0.44
2017 Fliegert R, Bauche A, Wolf Pérez AM, Watt JM, Rozewitz MD, Winzer R, Janus M, Gu F, Rosche A, Harneit A, Flato M, Moreau C, Kirchberger T, Wolters V, Potter BVL, et al. 2'-Deoxyadenosine 5'-diphosphoribose is an endogenous TRPM2 superagonist. Nature Chemical Biology. PMID 28671679 DOI: 10.1038/Nchembio.2415  0.44
2017 Fliegert R, Watt JM, Schöbel A, Rozewitz MD, Moreau C, Kirchberger T, Thomas MP, Sick W, Araujo AC, Harneit A, Potter BV, Guse AH. Ligand induced activation of human TRPM2 requires the terminal ribose of ADPR and involves Arg 1433 and Tyr 1349. The Biochemical Journal. PMID 28515263 DOI: 10.1042/Bcj20170091  0.44
Show low-probability matches.